Internal mammary lymph node drainage patterns in patients with breast cancer documented by breast lymphoscintigraphy

被引:76
作者
Byrd, DR
Dunnwald, LK
Mankoff, DA
Anderson, BO
Moe, RE
Yeung, RS
Schubert, EK
Eary, JF
机构
[1] Univ Washington, Med Ctr, Dept Gen Surg, Seattle, WA 98195 USA
[2] Univ Washington, Med Ctr, Sect Surg Oncol, Seattle, WA 98195 USA
[3] Univ Washington, Med Ctr, Div Nucl Med, Seattle, WA 98195 USA
关键词
internal mammary; lymphoscintigraphy; sentinel lymph node; breast cancer;
D O I
10.1007/s10434-001-0234-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Metastases to internal mammary lymph nodes (IMN) may occur in patients with breast cancer and may alter treatment recommendations. The purpose of this study was to identify the frequency of IMN drainage in patients undergoing boast lymphoscintigraphy and sentinel lymph node dissection (SLND). Methods: The combined technique of peritumoral injection of radiocolloid and Lymphazurin blue for SLND was performed on 220 patients. All patients underwent preoperative lymphoscintigraphy before SLND. Lesion location by quadrant included: 110 upper outer (UOQ), 49 lower outer (LOQ), 30 upper inner (UIQ), 24 lower inner (LIQ), and 7 central. Results: Drainage to any nodal basin was observed in 184 of 230 patients (84%). IMN drainage was documented in 37 of 220 (17%) of patients. IMN drainage without evidence of axillary drainage occurred in 2 of 220 patients(1%). Drainage to the IMN based on quadrant location of the lesion was as follows: UOQ, 10%; LOQ, 27%; UIQ, 17%; LIQ, 25%: and central, 29%. Conclusions: Internal mammary lymph node drainage shown by breast lymphoscintigraphy is common. Tumors in all quadrants may drain to IMNs, although drainage is significantly more common from quadrants other than the UOQ. Further studies are needed to determine whether lymphoscintigraphy drainage patterns identify patients at the highest risk for IMN metastases who may benefit from radiotherapy.
引用
收藏
页码:234 / 240
页数:7
相关论文
共 46 条
[1]   Lymphatic mapping and sentinel node biopsy in the patient with breast cancer [J].
Albertini, JJ ;
Lyman, GH ;
Cox, C ;
Yeatman, T ;
Balducci, L ;
Ku, NN ;
Shivers, S ;
Berman, C ;
Wells, K ;
Rapaport, D ;
Shons, A ;
Horton, J ;
Greenberg, H ;
Nicosia, S ;
Clark, R ;
Cantor, A ;
Reintgen, DS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (22) :1818-1822
[2]   Sentinel lymph node biopsy in breast cancer: Guidelines and pitfalls of lymphoscintigraphy and gamma probe detection [J].
Borgstein, P ;
Pijpers, R ;
Comans, EF ;
van Diest, PJ ;
Boom, RP ;
Meijer, S .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1998, 186 (03) :275-283
[3]   Internal mammary lymph nodes: To treat or not to treat [J].
Buchholz, TA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 46 (04) :801-803
[4]  
BUZDAR AU, 1990, CANCER, V65, P394, DOI 10.1002/1097-0142(19900201)65:3<394::AID-CNCR2820650303>3.0.CO
[5]  
2-2
[6]  
DONEGAN WL, 1977, CANCER-AM CANCER SOC, V39, P533, DOI 10.1002/1097-0142(197702)39:2<533::AID-CNCR2820390222>3.0.CO
[7]  
2-V
[8]  
Dunnwald L K, 1999, J Nucl Med Technol, V27, P106
[9]   Sentinel lymph node mapping for breast cancer: Analysis in a diverse patient group [J].
Eary, JF ;
Mankoff, DA ;
Dunnwald, LK ;
Byrd, DR ;
Anderson, BO ;
Yeung, RS ;
Moe, RE .
RADIOLOGY, 1999, 213 (02) :526-529
[10]   IDENTIFICATION OF A SUBGROUP OF PATIENTS WITH BREAST-CANCER AND HISTOLOGICALLY POSITIVE AXILLARY NODES RECEIVING ADJUVANT CHEMOTHERAPY WHO MAY BENEFIT FROM POSTOPERATIVE RADIOTHERAPY [J].
FOWBLE, B ;
GRAY, R ;
GILCHRIST, K ;
GOODMAN, RL ;
TAYLOR, S ;
TORMEY, DC .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (07) :1107-1117